LinkedIn

 آمار

تعداد نشریات21
تعداد شماره‌ها1,282
تعداد مقالات11,725
تعداد مشاهده مقاله82,705,028
تعداد دریافت فایل اصل مقاله121,597,500
Abbasi, Hosein, Vazin, Afsaneh, Moezzi, Seyed Mohammad Iman, Ahvar, Negar, Shorafa, Eslam, Hojabri, Katayoon, Abootalebi, Seyedeh Narjes, Javanmardi, Fatemeh, Shafiekhani, Mojtaba. (1404). Drug-drug interactions among pediatric intensive care unit: Risk factors and clinical Outcomes. سامانه مدیریت نشریات علمی, 12(1), -. doi: 10.30476/tips.2026.110716.1351
Hosein Abbasi; Afsaneh Vazin; Seyed Mohammad Iman Moezzi; Negar Ahvar; Eslam Shorafa; Katayoon Hojabri; Seyedeh Narjes Abootalebi; Fatemeh Javanmardi; Mojtaba Shafiekhani. "Drug-drug interactions among pediatric intensive care unit: Risk factors and clinical Outcomes". سامانه مدیریت نشریات علمی, 12, 1, 1404, -. doi: 10.30476/tips.2026.110716.1351
Abbasi, Hosein, Vazin, Afsaneh, Moezzi, Seyed Mohammad Iman, Ahvar, Negar, Shorafa, Eslam, Hojabri, Katayoon, Abootalebi, Seyedeh Narjes, Javanmardi, Fatemeh, Shafiekhani, Mojtaba. (1404). 'Drug-drug interactions among pediatric intensive care unit: Risk factors and clinical Outcomes', سامانه مدیریت نشریات علمی, 12(1), pp. -. doi: 10.30476/tips.2026.110716.1351
Abbasi, Hosein, Vazin, Afsaneh, Moezzi, Seyed Mohammad Iman, Ahvar, Negar, Shorafa, Eslam, Hojabri, Katayoon, Abootalebi, Seyedeh Narjes, Javanmardi, Fatemeh, Shafiekhani, Mojtaba. Drug-drug interactions among pediatric intensive care unit: Risk factors and clinical Outcomes. سامانه مدیریت نشریات علمی, 1404; 12(1): -. doi: 10.30476/tips.2026.110716.1351

Drug-drug interactions among pediatric intensive care unit: Risk factors and clinical Outcomes

Trends in Pharmaceutical Sciences and Technologies
دوره 12، شماره 1، خرداد 2026
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.30476/tips.2026.110716.1351
نویسندگان
Hosein Abbasi1؛ Afsaneh Vazin1؛ Seyed Mohammad Iman Moezzi2؛ Negar Ahvar1؛ Eslam Shorafa3؛ Katayoon Hojabri3؛ Seyedeh Narjes Abootalebi3؛ Fatemeh Javanmardi4؛ Mojtaba Shafiekhani* 1
1Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
2Department of Pharmaceutics, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3Department of Pediatrics, Division of Intensive Care Unit, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
4Department of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Objectives: To determine the frequency, risk factors, and clinical outcomes of drug–drug interactions (DDIs) in a pediatric intensive care unit (PICU).
Methods: We conducted a cross-sectional study (June 2022–February 2023) of children admitted ≥48 hours to medical or surgical PICUs with ≥2 prescribed medications. DDIs were identified and classified using Lexi-Interact®. Demographic/clinical data and medications were collected prospectively; severity and reliability ratings were recorded. Associations with DDIs were analysed using univariable and multivariable logistic regression.
Results: Among 345 included patients, 1858 DDIs were detected; category C: 1248 (≈67%), category D: 529 (≈29%), category X: 81 (≈4%). DDIs were more frequent in the medical PICU than the surgical PICU. The most frequent contraindicated (X) interaction involved linezolid–methadone. In multivariable analysis, the number of prescribed drugs and use of sedatives were independent predictors of DDIs; ward type (medical vs surgical) was also associated with higher DDI burden.
Conclusions: DDIs were common in this PICU cohort. Polypharmacy—particularly involving sedatives—was the principal modifiable risk factor. Heightened monitoring and stewardship targeting high-risk combinations may mitigate DDI-related harm
کلیدواژه‌ها
Pediatrics؛ Critical care؛ Intensive care unit؛ Drug Interactions؛ Medication Errors
آمار
تعداد مشاهده مقاله: 4


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب